We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+10.5%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$461M
AUM Growth
+$117M
Cap. Flow
+$81.3M
Cap. Flow %
17.64%
Top 10 Hldgs %
41.02%
Holding
99
New
12
Increased
35
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$13.3M
2
HUM icon
Humana
HUM
+$12M
3
TMO icon
Thermo Fisher Scientific
TMO
+$10.7M
4
AAPL icon
Apple
AAPL
+$5.41M
5
MSFT icon
Microsoft
MSFT
+$4.78M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$9.98M
2
ADBE icon
Adobe
ADBE
+$6.4M
3
ELAN icon
Elanco Animal Health
ELAN
+$2.14M
4
CSL icon
Carlisle Companies
CSL
+$1.33M
5
MRVL icon
Marvell Technology
MRVL
+$1.32M

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 20.03%
3 Consumer Discretionary 15.74%
4 Financials 15%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
51
Oracle
ORCL
$364B
$1.17M 0.25%
+9,800
New +$1.01M
CSL icon
52
Carlisle Companies
CSL
$14B
$1.15M 0.25%
4,500
-6,000
-57% -$1.33M
IR icon
53
Ingersoll Rand
IR
$32.2B
$1.14M 0.25%
+17,500
New +$1.03M
BSX icon
54
Boston Scientific
BSX
$65.4B
$1.08M 0.23%
19,900
– –
F icon
55
Ford
F
$56.7B
$1.07M 0.23%
71,000
– –
CMI icon
56
Cummins
CMI
$89.5B
$1.02M 0.22%
4,150
– –
ADBE icon
57
Adobe
ADBE
$94.3B
$978K 0.21%
2,000
-15,880
-89% -$6.4M
CE icon
58
Celanese
CE
$5.01B
$973K 0.21%
8,400
– –
BAC icon
59
Bank of America
BAC
$430B
$904K 0.2%
31,500
– –
TMUS icon
60
T-Mobile US
TMUS
$208B
$875K 0.19%
6,300
+2,800
+80% +$393K
DHR icon
61
Danaher
DHR
$144B
$864K 0.19%
4,061
-20
-0.5% -$4.23K
FITB
62
Fifth Third Bancorp
FITB
$52.6B
$852K 0.18%
+32,500
New +$838K
IFF icon
63
International Flavors & Fragrances
IFF
$20B
$852K 0.18%
10,700
– –
PEP icon
64
PepsiCo
PEP
$187B
$821K 0.18%
4,433
– –
LOW icon
65
Lowe's Companies
LOW
$117B
$790K 0.17%
3,500
– –
MCD icon
66
McDonald's
MCD
$190B
$769K 0.17%
2,578
-35
-1% -$10.2K
DASH icon
67
DoorDash
DASH
$80.2B
$764K 0.17%
10,000
– –
MAR icon
68
Marriott International
MAR
$96.6B
$735K 0.16%
4,000
– –
MDB icon
69
MongoDB
MDB
$25.1B
$709K 0.15%
+1,725
New +$503K
LMT icon
70
Lockheed Martin
LMT
$117B
$668K 0.14%
1,450
– –
CAT icon
71
Caterpillar
CAT
$405B
$664K 0.14%
2,700
– –
PG icon
72
Procter & Gamble
PG
$349B
$654K 0.14%
4,309
-73
-2% -$11K
STX icon
73
Seagate
STX
$178B
$637K 0.14%
10,300
-3,200
-24% -$195K
MRK icon
74
Merck
MRK
$315B
$635K 0.14%
5,500
-103
-2% -$11.7K
INTU icon
75
Intuit
INTU
$79.6B
$619K 0.13%
1,350
-700
-34% -$307K
1 2
3
4

Similar funds

RC
Randolph Company Cincinnati, Ohio $1.05B AUM 35.91% 1-Year Est. Return
LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.05B AUM 25.3% 1-Year Est. Return
HWCM
Hudson Way Capital Management Dallas, Texas $1.05B AUM 6.84% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return
AAIM
Asset Advisors Investment Management Augusta, Georgia $1.05B AUM 12.32% 1-Year Est. Return
CIA
CCM Investment Advisers Columbia, South Carolina $1.04B AUM 40.82% 1-Year Est. Return
TPWA
TRUE Private Wealth Advisors Salem, Oregon $1.05B AUM 19.14% 1-Year Est. Return

Waycross Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Waycross Partners held 99 positions worth $461M, up 34% from $344M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Waycross Partners deployed $81.3M of net new capital in Q2 2023, opening 12 new positions and adding to 35 existing holdings. Its largest new stake was Thermo Fisher Scientific: 19,775 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Eli Lilly, an estimated $9.98M trimmed.

  • Waycross Partners's largest Q2 2023 buy was Thermo Fisher Scientific: 19,775 shares worth $10.3M.
  • Waycross Partners added most to Target in Q2 2023, an estimated $13.3M increase.
  • Waycross Partners's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $9.98M.
  • Waycross Partners fully exited Elanco Animal Health in Q2 2023, selling an estimated $2.14M.
  • Waycross Partners's ten largest holdings make up 41% of its $461M portfolio in Q2 2023.
  • Waycross Partners opened 12 new positions and closed 4 in Q2 2023.
  • Waycross Partners's portfolio value rose 34% quarter-over-quarter to $461M.

Based on Waycross Partners's 13F filing for Q2 2023, filed 26 Jul 2023.